Sudden Cardiac Death and Antipsychotic Drugs
- 1 December 2001
- journal article
- editorial
- Published by American Medical Association (AMA) in Archives of General Psychiatry
- Vol. 58 (12) , 1168-1171
- https://doi.org/10.1001/archpsyc.58.12.1168
Abstract
ANTIPSYCHOTIC drugs have revolutionized the treatment of psychotic and mood disorders since their introduction 50 years ago. Although psychiatric patients haveKeywords
This publication has 26 references indexed in Scilit:
- Myocarditis and Cardiomyopathy Associated with Clozapine Use in the United StatesNew England Journal of Medicine, 2001
- Ziprasidone hydrochloride approved for treatment of schizophrenia, but with major warningAmerican Journal of Health-System Pharmacy, 2001
- The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: Clinical and regulatory implications Report on a Policy Conference of the European Society of CardiologyCardiovascular Research, 2000
- QTc-interval abnormalities and psychotropic drug therapy in psychiatric patientsThe Lancet, 2000
- Cardiovascular Adverse Effects of Antipsychotic DrugsDrug Safety, 2000
- Myocarditis and cardiomyopathy associated with clozapineThe Lancet, 1999
- Electrocardiographic changes in patients receiving neuroleptic medicationActa Psychiatrica Scandinavica, 1996
- Cardiotoxicity More Common in Thioridazine Overdose than with Other NeurolepticsJournal of Toxicology: Clinical Toxicology, 1995
- A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in FinlandActa Psychiatrica Scandinavica, 1991
- Phenothiazine Deaths: A Critical ReviewAmerican Journal of Psychiatry, 1973